Estimate Recalculated Nov 1, 2024 09:11AM EST
Harvey B Cash has an estimated net worth of $29.4 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, CORGENTECH INC, AIRSPAN NETWORKS INC, Argo Group International Holdings, Ltd., Trius Therapeutics Inc, CIENA CORP, MICROTUNE INC, INTRALASE CORP, MACROGENICS INC, APPLIED GENETIC TECHNOLOGIES CORP, Transcept Pharmaceuticals Inc, SILICON LABORATORIES INC, EPOCRATES INC, ENTORIAN TECHNOLOGIES INC, FIRST ACCEPTANCE CORP /DE/, ARGONAUT GROUP INC, I2 TECHNOLOGIES INC, MYOGEN INC, and METABASIS THERAPEUTICS INC.
Harvey B Cash's CIK is 0001198704
2011 was Harvey B Cash's most active year for acquiring shares with 11 total transactions. Harvey B Cash's most active month to acquire stocks was the month of April. 2008 was Harvey B Cash's most active year for disposing of shares, totalling 12 transactions. Harvey B Cash's most active month to dispose stocks was the month of May. 2017 saw Harvey B Cash paying a total of $525,478.80 for 32,638 shares, this is the most they've acquired in one year. In 2011 Harvey B Cash cashed out on 141,200 shares for a total of $5,854,696.06, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!